Lawrence T. Kennedy Jr - May 21, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Lawrence T. Kennedy, Jr.
Stock symbol
BDSX
Transactions as of
May 21, 2024
Transactions value $
$0
Form type
4
Date filed
5/23/2024, 07:14 PM
Previous filing
Apr 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +1.74M +16.52% 12.3M May 23, 2024 By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 F1
transaction BDSX Common Stock Options Exercise +2.61M +1565.24% 2.78M May 23, 2024 By: KFDI-B LLC F1
holding BDSX Common Stock 10.3M May 21, 2024 By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +46.7K $0.00 46.7K May 21, 2024 Common Stock 46.7K Direct F3, F4, F5
transaction BDSX Stock Options (Right to Buy) Award $0 +37.1K $0.00 37.1K May 21, 2024 Common Stock 37.1K $1.57 Direct F6
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -43.5K -100% $0.00* 0 May 23, 2024 Common Stock 1.74M By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 F1
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -65.2K -100% $0.00* 0 May 23, 2024 Common Stock 2.61M By: KFDI-B LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2 Reported amount has been adjusted to reflect the September 18, 2023 transfer of 687,515 shares of Common Stock previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 and the March 11, 2024 transfer of 34,526 shares of Common Stock previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 (the "March 11, 2024 Transfer"), each of which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act. The Lair BDSX GRAT 2022-3.2 ceased to beneficially own any shares of Common Stock following the March 11, 2024 Transfer.
F3 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
F4 These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F5 Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
F6 This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.